Print Friendly, PDF & Email

NCT/Study#

NCT03841110 /

FT500-101

FT500 As Monotherapy And In Combination With Immune Checkpoint Inhibitors In Subjects With Advanced Solid Tumors (Phase 1)

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase I

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587